ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · Real-Time Price · USD
1.895
+0.115 (6.46%)
Mar 9, 2026, 4:00 PM EDT - Market closed
ProQR Therapeutics Employees
ProQR Therapeutics had 166 employees as of December 31, 2024. The number of employees increased by 10 or 6.07% compared to the previous year.
Employees
166
Change (1Y)
10
Growth (1Y)
6.07%
Revenue / Employee
$113,543
Profits / Employee
-$300,699
Market Cap
199.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Molecular Partners AG | 153 |
| Heron Therapeutics | 128 |
| Nkarta | 105 |
| Tenaya Therapeutics | 97 |
| Compugen | 74 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
PRQR News
- 5 days ago - ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference - GlobeNewsWire
- 4 weeks ago - ProQR Announces Planned Changes to Board Composition - GlobeNewsWire
- 2 months ago - ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook - GlobeNewsWire
- 3 months ago - ProQR to Participate in 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 4 months ago - ProQR Announces Third Quarter 2025 Operating and Financial Results - GlobeNewsWire
- 4 months ago - ProQR Therapeutics N.V. (PRQR) Shareholder/Analyst Call Transcript - Seeking Alpha
- 5 months ago - ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025 - GlobeNewsWire
- 5 months ago - ProQR to Participate in Upcoming Investor Conferences in October 2025 - GlobeNewsWire